{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:32:20Z","timestamp":1769185940113,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.cct.2011.09.019","type":"journal-article","created":{"date-parts":[[2011,10,15]],"date-time":"2011-10-15T08:39:03Z","timestamp":1318667943000},"page":"184-196","source":"Crossref","is-referenced-by-count":31,"title":["Anticholinergic versus botulinum toxin A comparison trial for the treatment of bothersome urge urinary incontinence: ABC trial"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct01166438","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Anthony G.","family":"Visco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Brubaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly E.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Nygaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Fidela","family":"Paraiso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn A.","family":"Menefee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Janz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathie","family":"Spino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2011.09.019_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"issue":"187","key":"10.1016\/j.cct.2011.09.019_bb0205","first-page":"1","article-title":"Treatment of Overactive Bladder in Women","author":"Hartmann","year":"2009","journal-title":"Evid Rep Technol Assess (Summ) (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No 290-2007-10065-I) AHRQ Publication No 09-E017 Rockville, MD: Agency for Healthcare Research and Quality"},{"key":"10.1016\/j.cct.2011.09.019_bb0015","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/fampra\/cml018","article-title":"Perceptions and behaviours of women with bladder control problems","volume":"23","author":"Diokno","year":"2006","journal-title":"Fam Pract"},{"key":"10.1016\/j.cct.2011.09.019_bb0020","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.cct.2011.09.019_bb0025","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","article-title":"Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial","volume":"177","author":"Sahai","year":"2007","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.cct.2011.09.019_bb0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.juro.2008.03.028","article-title":"Refractory idiopathic urge urinary incontinence and botulinum A injection","volume":"180","author":"Brubaker","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.cct.2011.09.019_bb0035","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","article-title":"Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study","volume":"192","author":"Werner","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cct.2011.09.019_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","article-title":"Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics","volume":"176","author":"Schmid","year":"2006","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.cct.2011.09.019_bb0210","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.juro.2010.08.021","article-title":"Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial","volume":"184","author":"Dmochowski","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.cct.2011.09.019_bb0050","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.juro.2009.01.037","article-title":"Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence","volume":"181","author":"Wu","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.cct.2011.09.019_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-149-3-200808050-00005","article-title":"Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial","volume":"149","author":"Burgio","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cct.2011.09.019_bb0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2318-10-60","article-title":"Community based intervention to optimize osteoporosis management: randomized controlled trial","volume":"10","author":"Ciaschini","year":"2010","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.cct.2011.09.019_bb0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1513\/pats.200706-072JK","article-title":"Usual care as the control group in clinical trials of nonpharmacologic interventions","volume":"4","author":"Thompson","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.cct.2011.09.019_bb0070","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.3399\/bjgp10X514819","article-title":"How usual is usual care in pragmatic intervention studies in primary care? An overview of recent trials","volume":"60","author":"Smelt","year":"2010","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cct.2011.09.019_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1464-410X.2004.04606.x","article-title":"Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder","volume":"93","author":"Chapple","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.cct.2011.09.019_bb0215","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.juro.2007.05.058","article-title":"Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial","volume":"178","author":"Staskin","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.cct.2011.09.019_bb0085","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.clinthera.2008.10.011","article-title":"Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study","volume":"30","author":"Chancellor","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.cct.2011.09.019_bb0090","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/01.ju.0000140729.07840.16","article-title":"Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder","volume":"172","author":"Cardozo","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.cct.2011.09.019_bb0220","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/01.ju.0000127742.73136.0c","article-title":"Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial","volume":"171","author":"Zinner","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.cct.2011.09.019_bb0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00192-005-0023-4","article-title":"Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence","volume":"17","author":"Kelleher","year":"2006","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.cct.2011.09.019_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.urology.2005.08.017","article-title":"Multicenter phase III trial studying trospium chloride in patients with overactive bladder","volume":"67","author":"Rudy","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.cct.2011.09.019_bb0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/PL00004021","article-title":"Reproducibility of the seven-day voiding diary in women with stress urinary incontinence","volume":"11","author":"Nygaard","year":"2000","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.cct.2011.09.019_bb0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/nau.20110","article-title":"Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ)","volume":"24","author":"Matza","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.cct.2011.09.019_bb0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/nau.20342","article-title":"The responsiveness of the OAB-q among OAB patient subgroups","volume":"26","author":"Coyne","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.cct.2011.09.019_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","article-title":"Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)","volume":"193","author":"Barber","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cct.2011.09.019_bb0130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"10.1016\/j.cct.2011.09.019_bb0225","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00192-003-1063-2","article-title":"A short form of the Pelvic Organ Prolapse\/Urinary Incontinence Sexual Questionnaire (PISQ-12)","volume":"14","author":"Rogers","year":"2003","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.cct.2011.09.019_bb0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/14737167.5.1.23","article-title":"PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies","volume":"5","author":"Koopmanschap","year":"2005","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2011.09.019_bb0145","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/j.1524-4733.2005.00066.x","article-title":"Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers","volume":"8","author":"Atkinson","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.cct.2011.09.019_bb0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1524-4733.2008.00413.x","article-title":"Estimating a preference-based single index from the Overactive Bladder Questionnaire","volume":"12","author":"Yang","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.cct.2011.09.019_bb0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hec.944","article-title":"Estimating mean QALYs in trial-based cost\u2013effectiveness analysis: the importance of controlling for baseline utility","volume":"14","author":"Manca","year":"2005","journal-title":"Health Econ"},{"key":"10.1016\/j.cct.2011.09.019_bb0160","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.mlr.0000135827.18610.0d","article-title":"The estimation of a preference-based measure of health from the SF-12","volume":"42","author":"Brazier","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.cct.2011.09.019_bb0165","series-title":"Multiple imputation for nonresponse in surveys","author":"Rubin","year":"1987"},{"key":"10.1016\/j.cct.2011.09.019_bb0170","series-title":"Statistical analysis with missing data","author":"Little","year":"1987"},{"key":"10.1016\/j.cct.2011.09.019_bb0175","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrics"},{"key":"10.1016\/j.cct.2011.09.019_bb0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0090-4295(97)00599-2","article-title":"Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis","volume":"50","author":"Appell","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.cct.2011.09.019_bb0185","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/01.smj.0000220888.88722.ab","article-title":"Effectiveness of repeated treatment with botulinum toxin type A across different conditions","volume":"99","author":"Gordon","year":"2006","journal-title":"South Med J"},{"key":"10.1016\/j.cct.2011.09.019_bb0190","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","article-title":"Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity","volume":"68","author":"Karsenty","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.cct.2011.09.019_bb0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/nau.20332","article-title":"Predicting implantation with a neuromodulator using two different test stimulation techniques: a prospective randomized study in urge incontinent women","volume":"26","author":"Borawski","year":"2007","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.cct.2011.09.019_bb0200","first-page":"260","article-title":"Refractory urge urinary incontinence and botulinum a injection: the methods of the RUBI trial","volume":"6","author":"Brubaker","year":"2006","journal-title":"J Appl Res"},{"issue":"5","key":"10.1016\/j.cct.2011.09.019_bb0235","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.urology.2006.05.054","article-title":"Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?","volume":"68","author":"Kuo","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.cct.2011.09.019_bb0240","series-title":"American Urological Association Annual Meeting","article-title":"Experience including 5year results of 180 cases treated with low-dose (100U) botulinum-A toxin injections in the detrusor muscle for overactive bladder regractory to anticholinergics. Anaheim, CA: American Urological Association Annual Meeting","author":"Schmid","year":"2007"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714411002552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714411002552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T01:49:18Z","timestamp":1593136158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714411002552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1551714411002552"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2011.09.019","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}